Influence of haemodialysis and left ventricular failure on peripheral A2A adenosine receptor expression

Nephrology Dialysis Transplantation

Volumn 22, Issue 3, 2007, Pages 851-856

  Carrega, Louis ^a,b   Fenouillet, Emmanuel ^a   Giaime, Philippe ^a,c   Charavil, Annie ^b   Mercier, Laurence ^b   Gerolami, Victoria ^b   Berge Lefranc, Jean Louis ^b   Berland, Yvon ^c,e   Ruf, Jean ^f   Saadjian, Alain ^d   Dussol, Bertrand ^c   Guieu, Regis ^a,b  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d HÔPITAL NORD   (France)

^e HÔPITAL SAINTE MARGUERITE   (France)

^f INSERM   (France)

Author keywords

Adenosine; Cardiac failure; Chronic renal failure; Haemodialysis

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MESSENGER RNA;

ADULT; AGED; ARTICLE; CELL ISOLATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VALVULAR HEART DISEASE;

EID: 33847659952     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl665     Document Type: Article

References (33)

1. Descamps-Latscha B. The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 1993; 2: 883-891
2. Charney DI, Walton DF, Cheung AK. Atherosclerosis in chronic renal failure. Curr Opin Nephrol Hypertens 1993; 2: 876-882
3. Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: A critical survey. Kidney Int 1993 [Suppl 41]: S135-142
4. Nishimura M, Hashimoto T, Kobayashi H et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 2004; 66: 811-819
5. London G. Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-309
6. Ritz E, Deppisch R, Stier E, Hansch G. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 1994; 9 [Suppl 2]: 165-172
7. Shinzato T, Miwa M, Nakai S et al. Role of adenosine in dialysis-induced hypotension. J Am Soc Nephrol 1994; 4: 1987-1994
8. Dussol B, Fenouillet E, Brunet P et al. Kinetic study of adenosine concentrations and the expression of adenosine deaminase in mononuclear cells during hemodialysis. Kidney Int 2004; 66: 1640-1646
9. Guieu R, Brunet P, Sampol J et al. Adenosine and hemodialysis in humans. J Investig Med 2001; 49: 56-67
10. Sampol J, Dussol B, Fenouillet E et al. High adenosine and deoxyadenosine concentrations in mononuclear cells of hemodialyzed patients. J Am Soc Nephrol 2001; 12: 1721-1728
11. Sollevi A. Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol 1986; 27: 319-349
12. Saadjian AY, Levy S, Franceschi F et al. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 2002; 106: 569-574
13. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-492
14. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptor. Pharmacol Rev 2001; 53: 527-552
15. Picano E, Abbracchio MP. Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector. Brain Res Bull 2000; 52: 75-82
16. Arif Hasan AZ, Abebe W, Mustafa SJ. Antagonism of coronary artery relaxation by adenosine A2A-receptor antagonist ZM241385. J Cardiovasc Pharmacol 2000; 35(2): 322-325
17. Varani K, Laghi-Pasini F, Camurri A et al. Peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 18 Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. FASEB J 2003; 17: 280-282
18. Ledent C, Vaugeois JM, Schiffmann SB. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997; 388: 674-8
19. Dobson JG,Jr., Fenton RA. Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res 1997; 34: 337-347
20. Monahan TS, Sawmiller DR, Fenton RA, Dobson JG,Jr. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol 2000; 279: H1472-1481
21. Guieu R, Sampieri F, Bechis G et al. Use of diodde array detector for adenosine plasma analysis. J Liq Chrom 1999; 22: 1829-1841
22. Guieu R, Sampieri F, Bechis G, Rochat H. The use of HPLC to evaluate the variations of blood coronary adenosine levels during percutaneous transluminal angioplasty. Clin Chim Acta 1994; 227: 185-194
23. Varani K, Gessi S, Dalpiaz A, Ongini E, Borea PA. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding. Br J Pharmacol 1997; 122: 386-392
24. Keddie JR, Poucher SM, Shaw GR, Brooks R, Collis MG. In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist. Eur J Pharmacol 1996; 301: 107-113
25. Poucher SM, Keddie JR, Singh P et al. The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol 1995; 115: 1096-1102
26. Varani K, Portaluppi F, Gessi S et al. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: Functional and biochemical aspects. Circulation 2000; 102: 285-289
27. Malaponte G, Bevelacqua V, Fatuzzo P et al. IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age. Nephrol Dial Transplant 2002; 17: 1964-1970
28. Capecchi PL, Camurri A, Pompella G et al. Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: A regulatory mechanism of inflammation. J Card Fail 2005; 11: 67-73
29. Fortin A, Harbour D, Fernandes M et al. Differential expression of adenosine receptors in human neutrophils: Up-regulation by specific Th1 cytokines and lipopolysaccharide. J leucok Biol 2006; 79: 574-585
30. Varani K, Manfredini R, Iannotta V et al. Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension. Hypertension 2002; 40: 909-913
31. Talukder MA, Morrison RR, Ledent C, Mustafa SJ. Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. J Cardiovasc Pharmacol 2003; 41: 562-570
32. Shinzato T, Nakai S, Odani H et al. Relationship between dialysis induced hypotension and adenosine released by ischemic tissue. Asaio 1992; 38: M286-290
33. Peyot ML, Gadeau AP, Dandre F et al. Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor. Circ Res 2000; 86: 76-85